Scar or recurrence - Comparison of MRI and color-coded ultrasound with echo signal amplifiers;Narbe oder rezidiv? Einsatz der signalverstärkten Doppler-sonographie im vergleich zur MRT

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 174, Issue 11, 2002, Pages 1395-1401

  Aichinger, U ^a   Schulz Wendtland, R ^a   Kramer S ^b   Lell, M ^a   Bautz, W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Breast carcinoma; Duplex sonography; Echo signal amplifier; Recurrence

Indexed keywords

SHU 508;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST CARCINOMA; CANCER RECURRENCE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; SCAR; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; TUMOR VASCULARIZATION;

BREAST; BREAST NEOPLASMS; CICATRIX; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASTECTOMY, MODIFIED RADICAL; NEOPLASM RECURRENCE, LOCAL; POLYSACCHARIDES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, MAMMARY;

EID: 0036858890     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35348     Document Type: Article

References (28)

1. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989; 320: 822-828
2. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995; 333 (22): 1456-1461
3. Fisher ER, Anderson S, Redmond C, Fisher B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 1992; 8: 161-166
4. Recht A, Silen W, Schnitt SJ, Connolly JL, Gelman RS, Rose MA, Silver B, Harris JR. Time-course of local recurrence following conservative surgery and radiation therapy for early stage breast cancer. Int J Radiat Oncol Biol Phys 1988; 15: 255-261
5. McMahon KE, Osborne DR, Davidson AL. Role of breast magnetic resonance imaging in difficult diagnostic situations. Med J Aust 2001; 175: 494-497
6. Rieber A, Merkle E, Zeitler H, Gorich J, Kreienberg R, Brambs HJ, Tomczak R. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr 1997; 21: 780-784
7. Heywang-Köbrunner SH, Viehweg P, Heinig A, Kuchler C. Contrast-enhanced MRI of the breast: Accuracy, value, controversies, solutions. Eur J Radiol 1997; 24: 94-108
8. Krämer S, Schulz-Wendtland R, Döinghaus K, Bautz W, Lang N. Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer. Anticancer Research 1998; 18: 2159-2162
9. Lewis-Jones HG, Withhouse GH, Leinster SJ. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol 1991; 43: 197-204
10. Milz P, Kessler M, Lienemann A, Opitz N, Reiser M. Blutflussdarstellung in herdbefunden der mamma mittels der Power-Doppler-Sonographie. Ein neuer ansatz zur dignitätsbeurteilung? Fortschr Röntgenstr 1998; 169: 236-244
11. Fiedler V, Neubauer KD, Schneiders A, Herzig P. Stellenwert der farbkodierten duplexsonographie bei der dignitätsbestimmung von mammatumoren. Fortschr Röntgenstr 1996; 165: 159-165
12. American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol, 1997; 15: 2149-2145
13. Sauer H, de Waal JC, Eiermann W, Hölzel D, Kegler M, Lutz L, Mahl G, Rauthe G, Schmid L, Sittek H, Sommer H, Stieber P, Untch M. Nachsorge. In: Sauer H (Hrsg.). Empfehlungen zur Diagnostik, Therapie und Nachsorge Mammakarzinome, Zuckschwerdt, 2001: 83-96
14. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196: 123-134
15. Kratzer W, Kächele V, Merkle E, Mason A, Büchner M, von Tirpiz C, Pfeiffer M. Kontrastverstärkte Power-Doppler-Sonographie: Vergleich verschiedener applikationsformen des ultraschallverstärkers levovist®. Fortschr Röntgenstr 2000; 172: 443-448
16. Orel SG, Troupin RH, Patterson EA, Fowble BL. Breast cancer recurrence after lumpectomy and irradiation: Role of mammography in detection. Radiology 1992; 183: 201-206
17. Dershaw DD, McCormick B, Osborne MP. Detection of local recurrence after conservative therapy for breast carcinoma. Cancer 1992; 15: 493-496
18. Philpotts LE, Lee CH, Haffty BG, Lange RC, Tocino I. Mammographic findings of recurrent breast cancer after lumpectomy and radiation therapy: Comparison with the primary tumor. Radiology 1996; 201: 767-771
19. Knopp MV, Hoffmann U, Brix G, Hawinghorst H, Junkermann HJ, Kaick Gvan. Schnelle MR-kontrastdynamik zur charakterisierung von tumoren. Erfahrungen bei der funktionellen MR-mammographie. Radiologe 1995; 35: 964-972
20. Folkman J. Anti-angiogenesis: A new concept for therapy of solid tumors. Ann Surg 1972; 175: 409-416
21. Delorme S, Knopp MV. Non-invasive vascular imaging: Assessing tumour vascularity. Eur Radiol 1998; 8: 517-527
22. Schlief A, Bauer A. Ultraschallkontrastmittel - Neue perspektiven in der ultraschalldiagnostik. Radiologe 1996; 36: 51-57
23. Winehouse J, Douek M, Holz K, Madjar H, Gillams A, Lees W, Baum M. Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence. British Journal of Surgery 1999; 86: 1198-1201
24. Stuhrmann M, Schwarz T, Schietzel M. Mammakarzinom-Rezidiv versus postoperative narbe. Sonographische differenzierung unter einsatz des ultraschall-kontrastmittels levovist®. Ultraschall in Med 2001; 22: 2-6
25. Raza S, Baum JK. Solid breast lesions: Evaluation with power Doppler US. Radiology 1997; 203: 164-168
26. Kook SH, Park HW, Lee YR, Lee Yu, Poe WK, Park YL. Evaluation of solid breast lesions with Power Doppler sonography. J Clin Ultrasound 1999; 27: 231-237
27. Huber S, Stiskal M, Steinbach R, Czembirek H. Vaskularisation von fibroadenomen: Kontrast-Harmonic-Imaging im vergleich mit kontrastverstärktem Power Doppler. Fortschr Röntgenstr 2000; 172: 830-835
28. Bäz E, Madjar H, Reuss C, Vetter M, Hackeloer B, Holz K. The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy. Ultrasound Obstet Gynecol 2000; 15: 377-382